Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 32Carcinoma, Hepatocellular 23Carcinoma, Non-Small-Cell Lung 16Small Cell Lung Carcinoma 11Ovarian Neoplasms 11Colorectal Neoplasms 11Sarcoma 9Lung Neoplasms 9Nasopharyngeal Carcinoma 7Neoplasms 6Breast Neoplasms 6Triple Negative Breast Neoplasms 5Head and Neck Neoplasms 5Glioma 5Esophageal Neoplasms 5Cholangiocarcinoma 5Recurrence 4Pancreatic Neoplasms 4Osteosarcoma 4Esophageal Squamous Cell Carcinoma 4Biliary Tract Neoplasms 4Advanced Gastric Cancer 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Solid Tumor 3Neoplasm Metastasis 3NSCLC 3Melanoma 3Gastrointestinal Neoplasms 3

Interventions

Oxaliplatin 4Gemcitabine 4Fluorouracil 3Capecitabine 3Tegafur 2Stents 2Radiofrequency Ablation 2Leucovorin 2Irinotecan 2toripalimab 1tislelizumab 1taxane 1surufatinib 1lenvatinib 1apixaban 1apatinib 1aldesleukin 1Urination 1Trastuzumab 1Tomography, X-Ray Computed 1Temozolomide 1Taxes 1Standard of Care 1Sorafenib 1S 1 (combination) 1Rivaroxaban 1Radiotherapy 1Polymerase Chain Reaction 1Platinum Compounds 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gallbladder Neoplasms × apatinib × Clear all
NCT03702491 2018-10-11

Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma

Eastern Hepatobiliary Surgery Hospital

Phase 2 Unknown
138 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡